These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Effect of probucol in hyperlipidemic patients during two years of administration. Parsons WB Am Heart J; 1978 Aug; 96(2):213-7. PubMed ID: 354360 [TBL] [Abstract][Full Text] [Related]
26. Probucol (Lorelco) in treatment of hyperlipemia. Murphy BF JAMA; 1977 Dec; 238(23):2537-8. PubMed ID: 199758 [TBL] [Abstract][Full Text] [Related]
27. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia. Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686 [TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non-insulin-dependent diabetes mellitus. Goldberg R; La Belle P; Zupkis R; Ronca P Am J Cardiol; 1990 Sep; 66(8):16B-21B. PubMed ID: 2206032 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of lovastatin in a six-month study: analysis by gender, age and hypertensive status. Kannel WB; D'Agostino RB; Stepanians M; D'Agostino LC Am J Cardiol; 1990 Sep; 66(8):1B-10B. PubMed ID: 2206030 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness of probucol in reducing plasma low-density lipoprotein cholesterol oxidation in hypercholesterolemia. Masana L; Bargalló MT; Plana N; LaVille A; Casals I; Solà R Am J Cardiol; 1991 Oct; 68(9):863-7. PubMed ID: 1927944 [TBL] [Abstract][Full Text] [Related]
32. [The effect of lovastatin in the treatment of primary hypercholesterolemia]. Chi JM; Li LS; Sun MZ Zhonghua Nei Ke Za Zhi; 1992 Jan; 31(1):32-4, 61. PubMed ID: 1395911 [TBL] [Abstract][Full Text] [Related]
33. Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: the Finnish Multicenter Study. Tikkanen MJ; Helve E; Jäättelä A; Kaarsalo E; Lehtonen A; Malbecq W; Oksa H; Pääkkönen P; Salmi J; Veharanta T Am J Cardiol; 1988 Nov; 62(15):35J-43J. PubMed ID: 3055922 [TBL] [Abstract][Full Text] [Related]
34. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia]. Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901 [TBL] [Abstract][Full Text] [Related]
35. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia. März W; Grützmacher P; Paul D; Siekmeier R; Schoeppe W; Gross W Int J Clin Pharmacol Ther; 1994 Feb; 32(2):92-7. PubMed ID: 8004365 [TBL] [Abstract][Full Text] [Related]
36. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up. Bradford RH; Shear CL; Chremos AN; Dujovne CA; Franklin FA; Grillo RB; Higgins J; Langendorfer A; Nash DT; Pool JL Am J Cardiol; 1994 Oct; 74(7):667-73. PubMed ID: 7942524 [TBL] [Abstract][Full Text] [Related]
37. A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemia. The Lovastatin Pravastatin Study Group. Am J Cardiol; 1993 Apr; 71(10):810-5. PubMed ID: 8456759 [TBL] [Abstract][Full Text] [Related]
38. Probucol: a new cholesterol-lowering drug effective in patients with type II hyperlipoproteinemia. Salel AF; Zelis R; Sodhi HS; Price J; Mason DT Clin Pharmacol Ther; 1976 Dec; 20(6):690-4. PubMed ID: 186224 [TBL] [Abstract][Full Text] [Related]
39. Low-dose colestipol plus probucol for hypercholesterolemia. Dujovne CA; Chernoff SB; Krehbiel P; Jackson B; DeCoursey S; Taylor H Am J Cardiol; 1984 Jun; 53(11):1514-8. PubMed ID: 6375337 [TBL] [Abstract][Full Text] [Related]
40. Clinical investigation on the hypolipidemic effect of simvastatin versus probucol in hemodialysis patients. Fiorini F; Patrone E; Castelluccio A Clin Ter; 1994 Sep; 145(9):213-7. PubMed ID: 7813167 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]